Search Results - "Teo, Hsiang Ling"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Hexamethylene Bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF-κB activity: Implications for cancer therapy by Dey, Anwesha, Wong, Eetsin, Kua, Nelly, Ling Teo, Hsiang, Tergaonkar, Vinay, Lane, David

    Published in Cell cycle (Georgetown, Tex.) (01-12-2008)
    “…Hexamethylene Bisacetamide (HMBA) is a hybrid polar compound originally developed as a differentiation inducing agent. We show in this study that HMBA can…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The human telomeric nucleosome displays distinct structural and dynamic properties by Soman, Aghil, Liew, Chong Wai, Teo, Hsiang Ling, Berezhnoy, Nikolay V, Olieric, Vincent, Korolev, Nikolay, Rhodes, Daniela, Nordenskiöld, Lars

    Published in Nucleic acids research (04-06-2020)
    “…Telomeres protect the ends of our chromosomes and are key to maintaining genomic integrity during cell division and differentiation. However, our knowledge of…”
    Get full text
    Journal Article
  4. 4

    Assessing the Efficacy of Mdm2/Mdm4-Inhibiting Stapled Peptides Using Cellular Thermal Shift Assays by Tan, Ban Xiong, Brown, Christopher J., Ferrer, Fernando J., Yuen, Tsz Ying, Quah, Soo Tng, Chan, Boon Hong, Jansson, Anna E., Teo, Hsiang Ling, Nordlund, Pär, Lane, David P.

    Published in Scientific reports (10-07-2015)
    “…Previous publications on stapled peptide inhibitors against Mdm2/Mdm4-p53 interactions have established that this new class of drugs have the potential to be…”
    Get full text
    Journal Article
  5. 5

    The structure and catalytic mechanism of human sphingomyelin phosphodiesterase like 3a – an acid sphingomyelinase homologue with a novel nucleotide hydrolase activity by Lim, Sing Mei, Yeung, Kit, Trésaugues, Lionel, Ling, Teo Hsiang, Nordlund, Pär

    Published in The FEBS journal (01-03-2016)
    “…Human sphingomyelinase phosphodiesterase like 3a (SMPDL3a) is a secreted enzyme that shares a conserved catalytic domain with human acid sphingomyelinase…”
    Get full text
    Journal Article
  6. 6

    Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF kappaB activity: implications for cancer therapy by Dey, Anwesha, Wong, Eetsin, Kua, Nelly, Teo, Hsiang Ling, Tergaonkar, Vinay, Lane, David

    Published in Cell cycle (Georgetown, Tex.) (01-12-2008)
    “…Hexamethylene Bisacetamide (HMBA) is a hybrid polar compound originally developed as a differentiation inducing agent. We show in this study that HMBA can…”
    Get full text
    Journal Article